Trial Profile
Long-term Persistence of Hepatitis A Immunity in Healthy Adults Vaccinated as Part of a Hepatitis A Universal Mass Vaccination Program
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2023
Price :
$35
*
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 01 Mar 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 29 Dec 2017 Planned End Date changed from 10 May 2018 to 28 Jan 2019.
- 29 Dec 2017 Planned primary completion date changed from 10 May 2018 to 28 Jan 2019.